These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19895691)

  • 1. Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo.
    Poirier MC; Olivero OA; Hardy AW; Franchini G; Borojerdi JP; Walker VE; Walker DM; Shearer GM
    AIDS Res Ther; 2009 Nov; 6():24. PubMed ID: 19895691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.
    Walker DM; Kajon AE; Torres SM; Carter MM; McCash CL; Swenberg JA; Upton PB; Hardy AW; Olivero OA; Shearer GM; Poirier MC; Walker VE
    Environ Mol Mutagen; 2009 Jul; 50(6):460-72. PubMed ID: 19334055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
    Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection.
    Van Rompay KK; Marthas ML; Ramos RA; Mandell CP; McGowan EK; Joye SM; Pedersen NC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2381-6. PubMed ID: 1489181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine.
    Murley JS; Nantajit D; Baker KL; Kataoka Y; Li JJ; Grdina DJ
    Radiat Res; 2008 May; 169(5):495-505. PubMed ID: 18439041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.
    Treskes M; Nijtmans L; Fichtinger-Schepman AM; van der Vijgh WJ
    Anticancer Res; 1992; 12(6B):2261-5. PubMed ID: 1338281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the Impact of CD8
    Rife Magalis B; Nolan DJ; Autissier P; Burdo TH; Williams KC; Salemi M
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sera from simian immunodeficiency virus-infected rhesus macaques inhibit lymphocyte proliferation.
    Tomar RH; Hinds P; Katz D; Schultz K
    J Clin Lab Anal; 1992; 6(5):297-301. PubMed ID: 1403349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
    PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy.
    Benlhassan-Chahour K; Penit C; Dioszeghy V; Vasseur F; Janvier G; Rivière Y; Dereuddre-Bosquet N; Dormont D; Le Grand R; Vaslin B
    J Virol; 2003 Dec; 77(23):12479-93. PubMed ID: 14610172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.